GlassScriptPhysician profile
Kendra R Hall
NPI 1982282372
$1,171.63
in general payments reported to CMS, 2019-2025
15 companies · $583 in 2025
The $583 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $14.67 · 2023: $132 · 2024: $441 · 2025: $583.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,156.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $218.79 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $178.64 | 2023-2025 | Jardiance |
| Pfizer INC. | $111.27 | 2023-2025 | |
| Glaxosmithkline, LLC. | $106.51 | 2024-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Exact Sciences Corporation | $101.11 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novo Nordisk INC | $97.42 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $88.24 | 2024-2025 | Mounjaro, Jardiance |
| Merck Sharp & Dohme LLC | $79.05 | 2024-2025 | Gardasil 9, Capvaxive, Gardasil |
| Bayer Healthcare Pharmaceuticals INC. | $76.69 | 2024-2025 | |
| Dexcom, INC. | $24.86 | 2025 | Dexcom G6 Transmitter |
| Novartis Pharmaceuticals Corporation | $21.48 | 2025 | |
| Phathom Pharmaceuticals, INC. | $20.02 | 2024 | Voquezna |
| Astrazeneca Pharmaceuticals LP | $17.33 | 2025 | Farxiga |
| Xeris Pharmaceuticals, INC. | $16.60 | 2024 | Gvoke Hypopen |
| Evoke Pharma, INC. | $13.62 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kendra Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.